Author:
Mo Xiaodong,Zhang Weilong,Fu Guomei,Chang Yingjun,Zhang Xiaohui,Xu Lanping,Wang Yu,Yan Chenhua,Shen Mengzhu,Wei Qiuxia,Yan Changjian,Huang Xiaojun
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Abe, R., Peng, T., Sailors, J., Bucala, R., and Metz, C.N. (2001). Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol (Baltimore, Md: 1950) 166, 747–753.
2. Berntsson, J., Nodin, B., Eberhard, J., Micke, P., and Jirström, K. (2016). Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Intl J Canc 139, 1129–1139.
3. Bodoor, K., Matalka, I., Hayajneh, R., Haddad, Y., and Gharaibeh, W. (2012). Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis. Asian Pac J Canc Prevention 13, 3037–3046.
4. Brissot, E., Labopin, M., Ehninger, G., Stelljes, M., Brecht, A., Ganser, A., Tischer, J., Kröger, N., Afanasyev, B., Finke, J., et al. (2019). Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT. Haematologica 104, 524–532.
5. Cai, Z., Fan, S., Sun, X., Mo, X., and Yang, G. (2023). Novel microfluidic device for measurable residual disease detection in acute leukemia. Innovation 4, 100408.